Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease
Sintini, Irene , Graff‐Radford, Jonathan , Singh, Neha Atulkumar , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Singh, Neha Atulkumar , Schwarz, Christopher G. , Machulda, Mary M. , Carlos, Arenn F. , Senjem, Matthew L. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 23, 2023 | Volume: 19 | Issue: 10 | Pages: 4396-4406

10.1002/alz.13396 | PMID 37485642 Get It

AbstractINTRODUCTIONAtypical variants of Alzheimer's disease (AD) include the visual variant, known as posterior cortical atrophy (PCA), and the language variant, known as logopenic progressive aphasia (LPA). Clinically, rates of disease progression differ between them.METHODSWe evaluated 34 PCA and 29 LPA participants. Structural magnetic resonance imaging and 18F‐flortaucipir positron emission tomography were performed at baseline and at 1‐year follow‐up. Rates of change in tau uptake and grey matter volumes were compared between PCA and LPA with linear mixed‐effects models and voxel‐based analyses.RESULTSPCA had faster rates of occipital atrophy. LPA had faster rates of left temporal atrophy and faster rates of tau accumulation in the parietal, right temporal, and occipital lobes. Age was negatively associated with rates of atrophy and tau accumulation.DISCUSSIONLongitudinal patterns of neuroimaging abnormalities differed between PCA and LPA, although with divergent results for tau accumulation and atrophy.HIGHLIGHTS The language variant of Alzheimer's disease accumulates tau faster than the visual variant. Each variant shows faster rates of atrophy than the other in its signature regions. Age negatively influences rates of atrophy and tau accumulation in both variants.
Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial
DeFoster, Ruth E. , Morgan, Robert J. , Leung, Jonathan G. , Schenzel, Holly , Vijapura, Priyanka, Kashiwagi, Deanne T. , Fischer, Karen M. , Philbrick, Kemuel L. , Kung, Simon , Leung, Jonathan G , Fischer, Karen M , Morgan, Robert J.

Mayo Clinic

Substance Use & Misuse | July 20, 2023 | Volume: 58 | Issue: 13 | Pages: 1643-1650

10.1080/10826084.2023.2236223 | PMID 37469099 Get It

Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple’s disease
Williamson, Katrina Ann , Yun, Mark, Arment, Courtney, Patnaik, Asha , Chang, Tara W, Bledsoe, Adam C. , Sae-Tia, Sutthichai, Shah, Aditya , Williamson, Katrina A, Shah, Aditya S , Yao, Qingping , Yun, Mark, Koster, Matthew J. , Samuels, Jonathan , Davis, John M.

Mayo Clinic

Rheumatology | July 19, 2023 | Volume: 63 | Issue: 5 | Pages: 1291-1296

10.1093/rheumatology/kead372 | PMID 37467078 Get It

Abstract Objectives Whipple’s disease (WD) results from infection of the bacteria Tropheryma whipplei (TW). This disease is characterized by macrophage infiltration of intestinal mucosa and primarily affects Caucasian males. Genetic studies of host susceptibility are scarce. Nucleotide-binding oligomerization domain containing protein 2 (NOD2) is an innate immune sensor, resides mainly in monocytes/macrophages and contributes to defence against infection and inflammatory regulation. NOD2 mutations are associated with autoinflammatory diseases. We report the association of NOD2 mutations with TW and WD for the first time. Methods A multicentre, retrospective study of three patients with WD was conducted. Patients received extensive multidisciplinary evaluations and were cared for by the authors. NOD2 and its association with infection and inflammation were schematically represented. Results All patients were Caucasian men and presented with years of autoinflammatory phenotypes, including recurrent fever, rash, inflammatory arthritis, gastrointestinal symptoms and elevated inflammatory markers. All patients underwent molecular testing using a gene panel for periodic fever syndromes and were identified to carry NOD2 mutations associated with NOD2-associated autoinflammatory disease. Despite initially negative gastrointestinal evaluations, repeat endoscopy with duodenal tissue biopsy ultimately confirmed WD. After initial ceftriaxone and maintenance with doxycycline and/or HCQ, symptoms were largely controlled, though mild relapses occurred in follow-up. Conclusion Both NOD2 and TW/WD are intensively involved in monocytes/macrophages. WD is regarded as a macrophage disease. NOD2 leucin-rich repeat–associated mutations in monocytes/macrophages cause functional impairment of these cells and consequently may make the host susceptible for TW infection and WD, especially in the setting of immunosuppression.
Response to “Give us some GRACE, we can't take the HINT”
Edlow, Jonathan A. , Carpenter, Christopher R. , Newman‐Toker, David E. , Bellolio, Fernanda , Bellolio, M Fernanda , Carpenter, Christopher R , Newman-Toker, David E

Mayo Clinic

Academic Emergency Medicine | July 18, 2023 | Volume: 30 | Issue: 10 | Pages: 1080-1082

10.1111/acem.14778 | PMID 37460899 Get It

Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
Wang, Ming‐Hsi , Friton, Jessica, Rebert, Nancy A. , Monroe, Kelly, Nix, Billy D., Raffals, Laura E. , Leighton, Jonathan A. , Pasha, Shabana F., Picco, Michael F., Newberry, Rodney D. , Achkar, Jean–Paul , Faubion, William A. , Friton, Jessica J, Newberry, Rodney D , Fiocchi, Claudio

Mayo Clinic

Clinical and Translational Gastroenterology | July 13, 2023 | Volume: 14 | Issue: 9 | Pages: e00615

10.14309/ctg.0000000000000615 | PMID 37440754 Get It

INTRODUCTION: Patients with ulcerative colitis (UC) who are likely to have primary sclerosing cholangitis (PSC) should be identified because PSC can influence UC clinical behavior and outcomes.The aim of this study was to establish a model incorporating clinical and genetic risk predictors that identifies patients with UC at risk of developing PSC. METHODS: We conducted a retrospective case-control study. Inflammatory bowel disease cohorts from multiple institutions were used as discovery and replicate datasets. Quality control criteria, including minor allele frequency, call rates, Hardy-Weinberg equilibrium, cryptic relatedness, and population stratification (through principal components), were used. Discriminative accuracy was evaluated with area under the receiver operating characteristic curve. RESULTS: Fifty-seven of 581 patients (9.8%) with UC had PSC. Multivariate analysis showed that patients with UC-PSC had more extensive disease (odds ratio [OR], 5.42; P = 1.57E-04), younger diagnosis age (younger than 20 years; OR, 2.22; P = 0.02), and less smoking (OR, 0.42; P = 0.02) than those with UC. After linkage disequilibrium pruning and multivariate analyses, 3 SNPs (rs3131621 at 6p21.33; rs9275596 and rs11244 at 6p21.32) at the HLA region were found associated with a 2- to 3-fold increased risk of PSC. Our model demonstrated good discriminatory power (area under the receiver operating characteristic curve, 88%). DISCUSSION: Three variants in HLA (6p21.3) region significantly distinguished patients with UC-PSC from patients with UC alone. Once further validated in an independent large cohort, our model could be used to identify patients with UC at risk of PSC, and it could also help guide disease management.
Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair
Camacho, Elvis , Bagameri, Gabor, Afoke, Jonathan , Afoke, Jonathan

Mayo Clinic

Heart | July 12, 2023 | Volume: 109 | Issue: 15 | Pages: 1145-1192

10.1136/heartjnl-2023-322553 | PMID 37438056 Get It

An Unusual Presentation of Pediatric Gastrointestinal Stromal Tumor
Cárdenas, María C. , Hamel, Benjamin , Weckwerth, Jody , Potter, Dean, Bofill-Garcia, Aliana M., Schwartz, Jonathan , Hassan, Sara , Gonzalez, Michelle , Cardenas, Maria Camila, Hassan, Sara, Storm, Andrew C.

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | July 12, 2023 | Volume: 77 | Issue: 5 | Pages: No page available

10.1097/mpg.0000000000003888 | PMID 37434284 Get It

Clinicoradiologic Criteria for the Diagnosis of Stroke-like Episodes in MELAS
Khasminsky, Vadim , Auriel, Eitan , Luckman, Judith, Eliahou, Ruth, Inbar, Edna , Pardo, Keshet, Landau, Yuval E., Barnea, Rani , Mermelstein, Maor , Shelly, Shahar , Naftali, Jonathan , Peretz, Shlomi , Landau, Yuval, Shahar, Shelly

Mayo Clinic

Neurology Genetics | July 5, 2023 | Volume: 9 | Issue: 4 | Pages: No page available

10.1212/nxg.0000000000200082 | PMID 37426458 Get It

A Pilot Randomized Clinical Trial of Base‐in Relieving Prism Spectacle Treatment of Intermittent Exotropia
Summers, Allison I. , Morrison, David G., Chandler, Danielle L. , Henderson, Robert J. , Leske, David A. , Walker, Kimberly R., Li, Zhuokai , Melia, B. Michele, Bitner, Derek P., Kurup, Sudhi P. , Allen, Megan, Phillips, Paul H. , Nash, David L. , Grigorian, A. Paula, Kraus, Courtney L. , Miller, Aaron M. , Titelbaum, Jenna R. , Kraker, Raymond T. , Holmes, Jonathan M. , Group, for the Pediatric Eye Disease Investigator, Chen, Angela M. , Cotter, Susan A. , Group, for the Pediatric Eye Disease Investigator, Holmes, Jonathan M.

Mayo Clinic

Optometry and Vision Science | July 3, 2023 | Volume: 100 | Issue: 7 | Pages: 432-443

10.1097/opx.0000000000002039 | PMID 37399233 Get It

SIGNIFICANCE This pilot randomized trial, the first to evaluate a specific base‐in relieving prism treatment strategy for childhood intermittent exotropia, did not support proceeding to a full‐scale clinical trial. Defining and measuring prism adaptation in children with intermittent exotropia are challenging and need further study. PURPOSE This study aimed to determine whether to proceed to a full‐scale trial of relieving base‐in prism spectacles versus refractive correction alone for children with intermittent exotropia. METHODS Children 3 years old to those younger than 13 years with distance intermittent exotropia control score of ≥2 points on the Intermittent Exotropia Office Control Scale (Strabismus 2006;14:147–150; 0 [phoria] to 5 [constant]), ≥1 episode of spontaneous exotropia, and 16 to 35∆ by prism‐and‐alternate‐cover test, who did not fully prism adapt on a 30‐minute in‐office prism‐adaptation test were randomized to base‐in relieving prism (40% of the larger of distance and near exodeviations) or nonprism spectacles for 8 weeks. A priori criteria to conduct a full‐scale trial were defined for the adjusted treatment group difference in mean distance control: “proceed” (≥0.75 points favoring prism), “uncertain” (>0 to <0.75 points favoring prism), or “do not proceed” (≥0 points favoring nonprism). RESULTS Fifty‐seven children (mean age, 6.6 ± 2.2 years; mean baseline distance control, 3.5 points) received prism (n = 28) or nonprism (n = 29) spectacles. At 8 weeks, mean control values were 3.6 and 3.3 points in prism (n = 25) and nonprism (n = 25) groups, respectively, with an adjusted difference of 0.3 points (95% confidence interval, −0.5 to 1.1 points) favoring nonprism (meeting our a priori “do not proceed” criterion). CONCLUSIONS Base‐in prism spectacles, equal to 40% of the larger of the exodeviations at distance or near, worn for 8 weeks by 3‐ to 12‐year‐old children with intermittent exotropia did not yield better distance control than refractive correction alone, with the confidence interval indicating that a favorable effect of 0.75 points or larger is unlikely. There was insufficient evidence to warrant a full‐scale randomized trial.
Outcomes of Elective and Non-elective Fenestrated-branched Endovascular Aortic Repair for Treatment of Thoracoabdominal Aortic Aneurysms
Dias‐Neto, Marina , Vacirca, Andrea , Huang, Ying , Baghbani‐Oskouei, Aidin , Jakimowicz, Tomasz , Mendes, Bernardo C. , Bertoglio, Luca , Gargiulo, Mauro , Dias, Nuno , Schanzer, Andres , Gasper, Warren J. , Mani, Kevin , Timaran, Carlos H. , Schneider, Darren B. , Pedro, Luís Mendes , Tsilimparis, Nikolaos , Sweet, Matthew P. , Eagleton, Matthew J. , Khashram, Manar, Jama, Katarzyna , Panuccio, Giuseppe , Rohlffs, Fiona, Chiesa, Roberto , Kahlberg, Andrea , Schurink, Geert Willem H. , Lemmens, Charlotte , Karelis, Angelos , Parodi, Ezequiel, Habib, Mohammed , Cólon, Jesus Porras, Pavarino, Felipe, Baig, Mirza S. , Crawford, Sean A. , Garcia, Rita , Ribeiro, Tiago , Alves, Gonçalo, Gonçalves, Frederico Bastos , Kappe, Kaj O. , Knippenberg, Samira Elize Mariko van , Tran, Bich L. , Gormley, Sinead , Oderich, Gustavo S. , Baghbani, Aidin , Panuccio, Giuseppe , Dias-Neto, Marina , Schneider, Darren B , Kölbel, Tilo , Sobocinski, Jonathan , Mees, Barend M.E. , Dias, Nuno , Beck, Adam W , Farber, Mark , Haulon, Stéphan , Ferreira, Emília, Yeung, Kak Khee , Khashram, Manar , Rohlffs, Fiona , Mésnard, Thomas , Gallitto, Enrico , Faggioli, Gianluca , Gomes, Vivian Carla , Wanhainen, Anders , Habib, Mohammed, Colon, Jesus Porras, Baig, Mirza S., Melo, Ryan Gouveia e , Zettervall, Sara L , Oderich, Gustavo S.

Mayo Clinic

Annals of Surgery | July 3, 2023 | Volume: 278 | Issue: 4 | Pages: 568-577

10.1097/sla.0000000000005986 | PMID 37395613 Get It

Objective: To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs). Background: FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described. Methods: Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006–2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair. Results: A total of 2603 patients (69% males; mean age 72±10 year old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2187 patients (84%) and non-elective repair in 416 patients [16%; 268 (64%) symptomatic, 148 (36%) ruptured]. Non-elective FB-EVAR was associated with higher early mortality (17% vs 5%, P<0.001) and rates of MAEs (34% vs 20%, P<0.001). Median follow-up was 15 months (interquartile range, 7–37 months). Survival and cumulative incidence of ARM at 3 years were both lower for non-elective versus elective patients (50±4% vs 70±1% and 21±3% vs 7±1%, P<0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio, 1.92; 95% CI] 1.50–2.44; P<0.001) and ARM (hazard ratio, 2.43; 95% CI, 1.63–3.62; P<0.001). Conclusions: Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.